Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas [Phase 3]
Phase 3 trial comparing FFX to CPI-613 with mFFX in metastatic pancreatic adenocarcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-27Clinical Trial Update: A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating a PD-1 inhibitor with or without a vitamin D analog for maintenance therapy in pancreatic cancer has completed enro…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating irreversible electroporation (IRE) for locally advanced pancreatic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety trial of GEN1029 (HexaBody-DR5/DR5) in malignant solid tumors (termina ted; results posted in 2022).
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating concurrent chemoradiotherapy with immunotherapy in potentially resectable pancreatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine [Phase 2]
Phase 2 trial evaluating nab-paclitaxel plus gemcitabine as first-line treatment for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Nutrition and Pharmacological Algorithm for Oncology Patients Study [Phase 4]
Phase 4 trial update for a nutrition and pharmacological algorithm in oncology patients; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update of GSK2256098 with trametinib in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating FOLFIRINOX with or without SBRT in locally advanced pancreatic cancer has completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial update on neoadjuvant modified FOLFIRINOX with stereotactic body radiation therapy in borderline resectable pancreatic adenoca…
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer [Phase 1]
Phase 1 dose-escalation trial evaluating SBRT after induction chemotherapy for locally advanced pancreatic cancer is completed with results …
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial comparing Nanoliposomal Irinotecan (Nal-IRI)–containing regimens to nab-paclitaxel plus gemcitabine in previously untreated me…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy [Phase 1]
Phase 1 trial evaluating a neoantigen DNA vaccine in pancreatic cancer patients after surgery and adjuvant chemotherapy; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas [Phase 2]
Phase 2 study evaluating maintenance therapy after first-line chemotherapy in metastatic pancreatic cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating SBRT for locally advanced unresectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, with stated gastric, colon, rectal, esopha…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy [Phase 2]
Phase 2 trial evaluating regorafenib in metastatic solid tumors that progressed after standard therapy has completed, with multiple indicate…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer [Phase 2]
Phase 2 trial investigating nivolumab plus ipilimumab with radiation in metastatic pancreatic cancer is currently active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: First-line Therapy in Metastatic PDAC [Phase 2]
A Phase 2 clinical trial update investigating first-line therapy for metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating adjuvant GVAX vaccine therapy after surgery for pancreatic cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Effect of Hemp-CBD on Patients With CIPN [Phase 2]
Phase 2 clinical trial investigating the effect of hemp-derived CBD on chemotherapy-induced peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) [Phase 2]
Phase 2 clinical trial update for Flouro-Gem in pancreatic adenocarcinoma (GEFLUPAN) has completed enrollment; results not provided in snipp…
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer [Phase 3]
Phase 3 clinical trial evaluating organoid-guided adjuvant chemotherapy for pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer [Phase 3]
Phase 3 clinical trial update on organoid-guided chemotherapy for advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) [Phase 2]
A Phase 2 trial evaluating azacitidine for patients with resected pancreatic cancer has completed with posted results.